Published in Circulation on March 15, 1995
Evaluation of intracoronary stenting by intravascular optical coherence tomography. Heart (2003) 2.21
Is provisional stenting the effective option? The WIDEST study (Wiktor stent in de novo stenosis). Widest Trial Investigators' Group. Heart (2000) 1.48
Long term angiographic and clinical follow up in patients with stent implantation for symptomatic myocardial bridging. Heart (2000) 1.45
Safety of an abbreviated duration of dual antiplatelet therapy (≤6 months) following second-generation drug-eluting stents for coronary artery disease: A systematic review and meta-analysis of randomized trials. Catheter Cardiovasc Interv (2015) 1.39
Stent thrombosis and restenosis: what have we learned and where are we going? The Andreas Grüntzig Lecture ESC 2014. Eur Heart J (2015) 1.29
Entrapped coronary catheter remnants and stents: must they be surgically removed? Tex Heart Inst J (2006) 1.09
Coronary Palmaz-Schatz stent implantation in acute myocardial infarction. Heart (1996) 1.05
Virtual histology. Heart (2007) 1.03
Iatrogenic circumflex coronary lesion in mitral valve surgery: case report and review of the literature. Tex Heart Inst J (2008) 1.01
Long-term outcome after coronary stenting. Curr Control Trials Cardiovasc Med (2000) 1.00
Who was thrombogenic: the stent or the doctor? Circulation (1995) 0.97
Modeling of Soft Tissues Interacting with Fluid (Blood or Air) Using the Immersed Finite Element Method. J Biomed Sci Eng (2014) 0.94
Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol (2013) 0.92
Continued improvement of clinical outcome and cost effectiveness following intravascular ultrasound guided PCI: insights from a prospective, randomised study. Heart (2003) 0.92
Above genetics: lessons from cerebral development in autism. Transl Neurosci (2011) 0.90
Coating of cardiovascular stents with a semiconductor to improve their hemocompatibility. Tex Heart Inst J (1996) 0.90
Calibration-free device sizing using an inverse geometry x-ray system. Med Phys (2011) 0.90
Understanding coronary artery disease: tomographic imaging with intravascular ultrasound. Heart (2002) 0.89
Stent thrombosis: incidence, predictors and new technologies. Thrombosis (2012) 0.87
Utility of intravascular ultrasound in peripheral interventions. Tex Heart Inst J (1997) 0.87
C-reactive protein and fibrin clot strength measured by thrombelastography after coronary stenting. Blood Coagul Fibrinolysis (2013) 0.87
New advances in endovascular technology. Tex Heart Inst J (1997) 0.87
Heparin dose during percutaneous coronary intervention: how low dare we go? Heart (2002) 0.85
IVUS-Guided Stent Implantation to Improve Outcome: A Promise Waiting to be Fulfilled. Curr Cardiol Rev (2009) 0.85
Does intravascular ultrasound provide clinical benefits for percutaneous coronary intervention with bare-metal stent implantation? A meta-analysis of randomized controlled trials. Syst Rev (2012) 0.83
Ultrasound and light: friend or foe? On the role of intravascular ultrasound in the era of optical coherence tomography. Int J Cardiovasc Imaging (2011) 0.83
Hyperexpansion of coronary stents and clinical outcomes. Tex Heart Inst J (2006) 0.82
Long term outcome after coronary stent implantation: a 10 year single centre experience of 1000 patients. Heart (1999) 0.82
Recanalization of an accidentally crushed coronary stent by intravascular ultrasonography catheter entrapment. Korean Circ J (2011) 0.81
Ticlopidine and aspirin interactions. Heart (1997) 0.79
Effects of stent design and atherosclerotic plaque composition on arterial wall biomechanics. J Endovasc Ther (2008) 0.78
Intravascular ultrasound-guided emergency coronary Palmaz-Schatz stent placement without post-procedural systemic anticoagulation. Heart (1996) 0.78
Changing from intensive anticoagulation to treatment with aspirin alone for coronary stents: the experience of one centre in the United Kingdom. Heart (1996) 0.78
Perioperative management of antiplatelet therapy in patients with drug-eluting stents. HSR Proc Intensive Care Cardiovasc Anesth (2012) 0.78
Cocaine-induced coronary stent thrombosis. Exp Clin Cardiol (2013) 0.77
Can early closure and restenosis after endoluminal stenting be predicted from clinical, procedural, and angiographic variables at the time of intervention? Br Heart J (1995) 0.77
Early and intermediate term clinical outcome after multiple coronary stenting. Heart (1998) 0.77
Antiplatelet therapy following stent deployment. Heart (1997) 0.77
Effect of balloon inflation time on expansion of sirolimus-eluting stent. Heart Vessels (2009) 0.77
Antithrombotic therapy with intracoronary stenting. Heart (1997) 0.76
Ultrasonic image analysis and image-guided interventions. Interface Focus (2011) 0.76
Intracoronary Multi-link stents: experience in 218 patients using aspirin alone. Heart (1998) 0.75
Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2). PLoS One (2016) 0.75
Atherosclerosis imaging with intravascular ultrasound. Validating acquisition and measurement tools to assure meaningful results. Int J Cardiovasc Imaging (2006) 0.75
Who needs a stent? Heart (1997) 0.75
Catheter based intracoronary brachytherapy leads to increased platelet activation. Heart (2004) 0.75
The role of coronary angioplasty and stenting in acute myocardial infarction. Postgrad Med J (1999) 0.75
Antiplatelet treatment with cilostazol after stent implantation. Heart (1998) 0.75
3-Dimensional planning of endovascular procedures with multi-detector computed tomography (MDCT): impact on procedural results and clinical outcome? Int J Cardiovasc Imaging (2007) 0.75
Procedural and follow up results with a new balloon expandable stent in unselected lesions. Heart (1998) 0.75
Restenosis following coronary angioplasty: current status. Korean J Intern Med (2001) 0.75
Some thoughts on the present and future of coronary artery stenting. Heart (1996) 0.75
Single or dual antiplatelet therapy after PCI. Nat Rev Cardiol (2017) 0.75
What is the use of directional atherectomy, now we have stents? Heart (1997) 0.75
Intracoronary ultrasound. Postgrad Med J (1998) 0.75
Coronary artery stents. Postgrad Med J (1996) 0.75
Safety and efficacy of ticlopidine after stent placement. Circulation (2000) 0.75
A Case Report of Recurrent Subacute Stent Thrombosis After Drug Eluting Stent Implantation: What Is the Real Reason? Cardiol Res (2015) 0.75
Electrochemical and microstructural studies of tantalum and its oxide films for biomedical applications in endovascular surgery. J Mater Sci Mater Med (2002) 0.75
Coronary stents and vascular response to implantation: literature review. Pragmat Obs Res (2017) 0.75
The CAGE questionnaire: validation of a new alcoholism screening instrument. Am J Psychiatry (1974) 16.18
Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother (1990) 11.71
Pipemidic acid, a new antibacterial agent active against Pseudomonas aeruginosa: in vitro properties. Antimicrob Agents Chemother (1975) 8.67
Pipemidic acid: its activities against various experimental infections. Antimicrob Agents Chemother (1976) 7.92
Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol (1990) 7.61
CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat Genet (1994) 7.07
Pipemidic acid: absorption, distribution, and excretion. Antimicrob Agents Chemother (1975) 6.38
Quinolone-resistant mutations of the gyrA gene of Escherichia coli. Mol Gen Genet (1988) 6.30
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother (1991) 6.19
Nalidixic acid-resistant mutations of the gyrB gene of Escherichia coli. Mol Gen Genet (1986) 5.95
In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid. Antimicrob Agents Chemother (1983) 5.45
Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma. Biochem Biophys Res Commun (1993) 4.32
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus. Antimicrob Agents Chemother (1994) 3.96
Isolation of human glucose-6-phosphate dehydrogenase (G6PD) cDNA clones: primary structure of the protein and unusual 5' non-coding region. Nucleic Acids Res (1986) 3.86
New nalidixic acid resistance mutations related to deoxyribonucleic acid gyrase activity. J Bacteriol (1981) 3.65
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib. Leukemia (2008) 3.58
Discovery of a cool planet of 5.5 Earth masses through gravitational microlensing. Nature (2006) 3.53
Plasma immunoglobulin concentrations in a West African (Gambian) community and in a group of healthy British adults. Clin Exp Immunol (1968) 3.53
Seclusion in prison strip cells. BMJ (1993) 3.44
Dynamics and species richness of tropical rain forests. Proc Natl Acad Sci U S A (1994) 3.32
Efficient promoter cassettes for enhanced expression of foreign genes in dicotyledonous and monocotyledonous plants. Plant Cell Physiol (1996) 3.30
Effective elimination of drug resistance and sex factors in Escherichia coli by sodium dodecyl sulfate. J Bacteriol (1968) 3.22
[Low risk of cancer after treatment of hyperthyroidism with iodine-131]. Lakartidningen (1992) 3.22
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res (1998) 3.20
Electric-field-induced superconductivity in an insulator. Nat Mater (2008) 3.17
Mode of incomplete cross-resistance among pipemidic, piromidic, and nalidixic acids. Antimicrob Agents Chemother (1978) 3.12
Induction of programmed cell death (apoptosis) by influenza virus infection in tissue culture cells. J Gen Virol (1993) 3.08
Coronary artery imaging with intravascular high-frequency ultrasound. Circulation (1990) 2.97
AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science (1989) 2.93
Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. J Biol Chem (1991) 2.89
The small GTPase RalA targets filamin to induce filopodia. Proc Natl Acad Sci U S A (1999) 2.87
Alterations in the DNA topoisomerase IV grlA gene responsible for quinolone resistance in Staphylococcus aureus. Antimicrob Agents Chemother (1996) 2.84
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Molecular cloning and sequence determination of cDNAs for alpha subunits of the guanine nucleotide-binding proteins Gs, Gi, and Go from rat brain. Proc Natl Acad Sci U S A (1986) 2.83
Primary structure of elongation factor Tu from Escherichia coli. Proc Natl Acad Sci U S A (1980) 2.72
Structural analysis of the X-linked gene encoding human glucose 6-phosphate dehydrogenase. EMBO J (1986) 2.64
Pharmacokinetics of AT-2266 administered orally to mice, rats, dogs, and monkeys. Antimicrob Agents Chemother (1983) 2.58
C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins. Proc Natl Acad Sci U S A (1994) 2.57
Isolation of a second yeast Saccharomyces cerevisiae gene (GPA2) coding for guanine nucleotide-binding regulatory protein: studies on its structure and possible functions. Proc Natl Acad Sci U S A (1988) 2.54
Mechanism of action of quinolones against Escherichia coli DNA gyrase. Antimicrob Agents Chemother (1993) 2.48
Antigens associated with Plasmodium falciparum infections in man. Lancet (1969) 2.45
Prospective evaluation of serum CA 125 levels for early detection of ovarian cancer. Obstet Gynecol (1992) 2.43
Serine palmitoyltransferase is the primary target of a sphingosine-like immunosuppressant, ISP-1/myriocin. Biochem Biophys Res Commun (1995) 2.42
Staining of internal limiting membrane in macular hole surgery. Arch Ophthalmol (2000) 2.36
Diverse point mutations in the human glucose-6-phosphate dehydrogenase gene cause enzyme deficiency and mild or severe hemolytic anemia. Proc Natl Acad Sci U S A (1988) 2.33
Radiation-induced breast cancer: long-term follow-up of radiation therapy for benign breast disease. J Natl Cancer Inst (1993) 2.29
Evolutionary adaptation of plasmid-encoded enzymes for degrading nylon oligomers. Nature (1984) 2.29
Platelet-derived growth factor stimulates formation of active p21ras.GTP complex in Swiss mouse 3T3 cells. Proc Natl Acad Sci U S A (1990) 2.26
Primary stent implantation is superior to balloon angioplasty in acute myocardial infarction: final results of the primary angioplasty versus stent implantation in acute myocardial infarction (PASTA) trial. PASTA Trial Investigators. Catheter Cardiovasc Interv (1999) 2.23
Depth of invasion as a predictive factor for cervical lymph node metastasis in tongue carcinoma. Head Neck (1997) 2.21
Epstein-Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8-9 September 2008. Ann Oncol (2009) 2.20
Hepatic cytochrome P450 2E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology (1998) 2.19
Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study. Rheumatology (Oxford) (2005) 2.19
Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science (1988) 2.17
Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids. Arthritis Rheum (1999) 2.17
Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa. Antimicrob Agents Chemother (1990) 2.17
Occurrence in Saccharomyces cerevisiae of a gene homologous to the cDNA coding for the alpha subunit of mammalian G proteins. Proc Natl Acad Sci U S A (1987) 2.15
Surgical anatomy of the hepatic veins and the inferior vena cava. Surg Gynecol Obstet (1981) 2.12
Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet (1997) 2.12
Identification of Rap1 as a target for the Crk SH3 domain-binding guanine nucleotide-releasing factor C3G. Mol Cell Biol (1995) 2.10
Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. Proc Natl Acad Sci U S A (1997) 2.10
Second primary malignancies in thyroid cancer patients. Br J Cancer (2003) 2.10
Discovery of a Jupiter/Saturn analog with gravitational microlensing. Science (2008) 2.09
Malignancies of natural killer (NK) cell precursor: myeloid/NK cell precursor acute leukemia and blastic NK cell lymphoma/leukemia. Leuk Res (1999) 2.07
Unique features of the CAG repeats in Machado-Joseph disease. Nat Genet (1995) 2.06
Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor. Nucleic Acids Res (1985) 2.06
Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science (1992) 1.98
Detection of Norwalk-like virus genes in the caecum contents of pigs. Arch Virol (1998) 1.97
Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome. Arthritis Rheum (1996) 1.97
Chromogenic substrates for horseshoe crab clotting enzyme. Its application for the assay of bacterial endotoxins. Haemostasis (1978) 1.96
Complete nucleotide sequence of the gene for human interleukin 1 alpha. Nucleic Acids Res (1986) 1.95
Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study) Eur Heart J (1998) 1.95
Neurite outgrowth of PC12 cells is suppressed by wortmannin, a specific inhibitor of phosphatidylinositol 3-kinase. J Biol Chem (1994) 1.94
An Asian variant of intravascular large B-cell lymphoma: clinical, pathological and cytogenetic approaches to diffuse large B-cell lymphoma associated with haemophagocytic syndrome. Br J Haematol (2000) 1.93
Mammalian ELAV-like neuronal RNA-binding proteins HuB and HuC promote neuronal development in both the central and the peripheral nervous systems. Proc Natl Acad Sci U S A (1999) 1.93
CRK protein binds to two guanine nucleotide-releasing proteins for the Ras family and modulates nerve growth factor-induced activation of Ras in PC12 cells. Mol Cell Biol (1994) 1.92
Activity of AT-2266 compared with those of norfloxacin, pipemidic acid, nalidixic acid, and gentamicin against various experimental infections in mice. Antimicrob Agents Chemother (1983) 1.90
A randomized comparison of combined ticlopidine and aspirin therapy versus aspirin therapy alone after successful intravascular ultrasound-guided stent implantation. Circulation (1996) 1.90
Induction of neuronal differentiation in PC12 cells by B-cell stimulatory factor 2/interleukin 6. Mol Cell Biol (1988) 1.89
Discovery of superconductivity in KTaO₃ by electrostatic carrier doping. Nat Nanotechnol (2011) 1.89
Relation between smoking status of physicians and their enthusiasm to offer smoking cessation advice. Intern Med (1997) 1.88
Identification of a major growth factor for AIDS-Kaposi's sarcoma cells as oncostatin M. Science (1992) 1.85
Follicular dendritic cell sarcoma and interdigitating reticulum cell sarcoma: a review. Am J Hematol (1998) 1.85
Congenital dislocation of the knee reduced spontaneously or with minimal treatment. J Pediatr Orthop (1997) 1.84
Glucose-6-phosphate dehydrogenase plays a crucial role in protection from redox-stress-induced apoptosis. Cell Death Differ (2004) 1.82
Nucleotide sequence and expression in Escherichia coli of the gene coding for sphingomyelinase of Bacillus cereus. Eur J Biochem (1988) 1.80
A novel gene, MALT1 at 18q21, is involved in t(11;18) (q21;q21) found in low-grade B-cell lymphoma of mucosa-associated lymphoid tissue. Oncogene (1999) 1.78
Treatment of herpes simplex esophagitis in an immunocompetent patient with intravenous acyclovir: a case report and review of the literature. Am J Gastroenterol (1998) 1.78
Prevalence of genetic haemochromatosis among diabetic patients. Lancet (1989) 1.78
The community's tolerance of the mentally ill. Br J Psychiatry (1993) 1.77
Evaluation of the new system (umu-test) for the detection of environmental mutagens and carcinogens. Mutat Res (1985) 1.76
Treatment of spontaneous coronary artery dissection: report of three cases. Cathet Cardiovasc Diagn (1997) 1.76
Specific methylation pattern at the 3' end of the human housekeeping gene for glucose 6-phosphate dehydrogenase. EMBO J (1984) 1.75
OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther (1998) 1.74
Extensive resection of the bile ducts combined with liver resection for cancer of the main hepatic duct junction: a cooperative study of the Keio Bile Duct Cancer Study Group. Surgery (1994) 1.73
Apoptotic cell death of primed CD45RO+ T lymphocytes in Epstein-Barr virus-induced infectious mononucleosis. Blood (1992) 1.72
Alterations of the blood-brain barrier and glial cells in white-matter lesions in cerebrovascular and Alzheimer's disease patients. Stroke (1996) 1.71
Cancer risk after iodine-131 therapy for hyperthyroidism. J Natl Cancer Inst (1991) 1.71